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Background
• Healthy People 2020 establishes the goal that 80% of 
adolescents ages 13-15 will have completed the human 
papillomavirus (HPV) vaccination series by 2020.
• In 2015, the CDC estimated that only 41.9% of U.S. girls and 
28.1% of U.S. boys ages 13-17 had completed the 3-dose series. 
• Among 7 local areas surveyed by the 2015 National 
Immunization Survey, Philadelphia had the highest  ≥ 3 dose 
(58.6%) HPV vaccine uptake for girls. Rates for Philadelphia 
boys (≥ 3 dose = 43.4%) were higher than the U.S. average.
• Sociodemographic factors such as race/ethnicity, 
provider/insurance type, and income may affect series 
completion rates.
Research Aim
• This study analyzed data from the Philadelphia KidsPlus 
Immunization information System (IIS) to look at factors 
associated with HPV vaccine series completion. 
Methods
• The sample included 50,185 
Philadelphia-resident adolescents 
born between 2000 and 2003 who 
received at least 1 dose of HPV 
vaccine.
• HPV vaccination records were 
collected until 3/1/2016.
• Adolescents who took the first 
dose after 8/31/2015 were excluded 
to allow for a 6-month interval 
between doses 1 and 3.
• 𝜒2 tests were performed and 
followed by bivariate and 
multivariable logistic regression 
analysis to compare differences in 
HPV vaccine series completion 
across race/ethnicity, ZIP codes, 
provider type, and age. 
• A  2-dose analysis was 
performed given the 12/2016 
recommendation that adolescents 
who begin the series before age 15 
need only 2 doses of vaccine. 
Participants who reached age 15 
before 8/31/2015 were excluded 
from the 2-dose analysis.
Results
• 49.9% of females and 45.1% of males completed the 3-dose series. 
75.8% of females and 73.1% of males completed 2 doses. 
• Multivariable logistic regression analysis showed that for females, 
being Hispanic or Asian was associated with 3-dose series completion and 
receipt of 2 doses of vaccine.
• Lower-income females were less likely to complete the 3-dose series 
than the highest-income females. For 2 doses, only the second lowest 
income category was associated with lower odds of receipt.
• Hispanic and Asian males were more likely than white males to 
complete the 3-dose series and to receive 2 doses of vaccine. 
• For males, only the 101-150% FPG income category was associated 
with a different 3-dose completion rate than the highest income category. 
There were no income-related differences with receipt of 2 doses of 
vaccine.
Results
Discussion
• Hispanic and Asian race/ethnicity are predictors of 3-dose HPV vaccine 
series completion and 2-dose receipt in Philadelphia adolescents. 
• Lower-income Philadelphia females, and some low-income males, are less 
likely to complete the series than higher-income adolescents. 
• African American females have a higher risk of cervical cancer than white 
and Asian females, and they have the highest cervical cancer death rates of 
women in the U.S. They make up half of this study population, and their 
lower tendency to complete the HPV vaccination series in relation to Hispanic 
and Asian adolescents is an area of special concern and opportunity.
• In 2016, the Advisory Committee on Immunization Practices 
recommended that only 2 doses of vaccine are needed for adolescents who 
begin the series before age 15. This analysis did not detect differences in 2 
dose vs 3 dose receipt when looking at race and ethnicity. Some differences 
related to low income disappeared when looking at receipt of 2 doses. This 
may indicate that low-income Philadelphia adolescents will benefit from the 
new recommendation. 
• Using ZIP code as a proxy for income, lack of demographic information 
from the IIS, and lack of granularity regarding provider type are limitations of 
this study. Strengths are a large racially and ethnically diverse sample and the 
mature IIS from which the data are drawn.
• Further research is needed into factors that may differently affect series 
completion across the sociodemographic variables in this study. Such factors 
may include missed opportunities for vaccination, lack of high-quality 
provider recommendation, parental attitudes toward vaccination and health-
care providers, financial barriers, and so on.
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Table 1 Demographic Characteristics, Philadelphia recipients of at least 1 
dose HPV vaccine, birth years 2000-2003
Characteristics Female (n=25150) Male (n=24700)
Age
15 7033 (28.0) 6837 (27.7)
14 6585 (26.2) 6557 (26.5)
13 6145 (24.4) 5944 (24.1)
12 5387 (21.4) 5362 (21.7)
Race/Ethnicity
Black/African American 12259 (48.7) 12278 (49.7)
Hispanic 4497 (17.9) 4433 (17.9)
White 3528 (14.0) 3299 (13.4)
Asian 1194 (4.7) 1218 (4.9)
Unknown 2675 (10.6) 2490 (10.1)
Other 993 (3.9) 979 (4.0)
Income (% FPG)
≤100% 4082 (16.2) 4217 (17.1)
101-150% 10839 (43.1) 10733 (43.5)
151-200% 7253 (28.8) 7010 (28.4)
>200% 2963 (11.8) 2717 (11.0)
Provider Type
VFC Provider 18878 (75.1) 18597 (75.3)
Community HC/FQHC 3274 (13.0) 3205 (13.0)
Others 730 (2.9) 707 (2.9)
Dose 1 25150 (100) 24700 (100)
Dose 2 19055 (75.8) 18055 (73.1)
Dose ≥ 3 12544 (49.9) 11132 (45.1)
Abbreviations: FPG, Federal Poverty Guidelines, VFC, Vaccines for 
Children; HC, Health Center; FQHC, Federally Qualified Health Center
Table 2
Multivariable logistic regression analysis of factors associated with 3 dose HPV vaccination, Philadelphia 
adolescents birth years 2000-2003
Female (n=25150) Male (n=24700)
OR 95% CI OR 95% CI
Race/Ethnicity
African American 1.07 0.98-1.17 0.97 0.88-1.06
Hispanic 1.45* 1.31-1.60 1.42* 1.28-1.58
Asian 1.93* 1.66-2.25 1.72* 1.49-2.00
Unknown 0.94 0.84-1.05 0.80* 0.71-0.90
Other 1.15 0.97-1.35 1.10 0.94-1.30
White ref ref
Income (%FPG)
≤100% 0.84* 0.75-0.93 0.94 0.84-1.05
101-150% 0.79* 0.72-0.87 0.87* 0.79-0.96
151-200% 0.87* 0.79-0.95 0.92 0.83-1.01
>200% ref ref
Age
12 0.19* 0.18-0.21 0.22* 0.20-0.24
13 0.42* 0.39-0.45 0.43* 0.40-0.46
14 0.75* 0.69-0.80 0.83* 0.78-0.90
15 ref ref
Provider
Community HC/FQHC 0.98 0.91-1.06 0.92* 0.85-1.00
Others 0.94 0.80-1.09 1.18* 1.00-1.38
VFC Provider ref ref
*p<0.05
Table 3
Multivariable logistic regression analysis, 2 dose HPV vaccination, Philadelphia adolescents who began series 
before 15th birthday
Female (n=20432) Male ( n=20189)
OR 95% CI OR 95% CI
Race/Ethnicity
African American 1.08 0.97-1.21 1.00 0.89-1.11
Hispanic 1.52* 1.34-1.74 1.47* 1.29-1.68
Asian 1.81* 1.47-2.22 1.72* 1.42-2.09
Unknown 0.91 0.80-1.04 0.83* 0.73-0.95
Other 1.44* 1.17-1.78 1.18 0.97-1.43
White ref ref
Income (%FPG)
≤100% 0.90 0.78-1.03 1.04 0.91-1.19
101-150% 0.85* 0.75-0.95 0.92 0.82-1.04
151-200% 0.93 0.82-1.05 0.97 0.86-1.09
>200% ref ref
Age
12 0.24* 0.21-0.27 0.27* 0.24-0.31
13 0.45* 0.40-0.50 0.49* 0.44-0.55
14 0.72* 0.64-0.81 0.82* 0.74-0.92
15 ref ref
Provider
Community HC/FQHC 1.00 0.90-1.10 0.91 0.83-1.01
Others 0.77* 0.64-0.93 1.18 0.96-1.45
VFC Provider ref ref
*p<0.05
